98 related articles for article (PubMed ID: 9187397)
21. High performance liquid chromatographic determination of a new antifungal compound, ADKZ in rat plasma.
Wen J; Fan GR; Hong ZY; Chai YF; Yin XP; Wu YT; Sheng CQ; Zhang WN
J Pharm Biomed Anal; 2007 Jan; 43(2):655-8. PubMed ID: 16950589
[TBL] [Abstract][Full Text] [Related]
22. Chromatographic properties of cytosine, cytidine and their synthetic analogues.
Romanová D; Novotný L
J Chromatogr B Biomed Appl; 1996 Jan; 675(1):9-15. PubMed ID: 8634774
[TBL] [Abstract][Full Text] [Related]
23. Quantitative determination of Astragaloside IV, a natural product with cardioprotective activity, in plasma, urine and other biological samples by HPLC coupled with tandem mass spectrometry.
Zhang W; Zhang C; Liu R; Li H; Zhang J; Mao C; Chen C
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):170-7. PubMed ID: 15990371
[TBL] [Abstract][Full Text] [Related]
24. Determination of carboplatin in canine plasma by high-performance liquid chromatography.
Villarino N; Cox S; Yarbrough J; Martín-Jiménez T
Biomed Chromatogr; 2010 Aug; 24(8):908-13. PubMed ID: 20041399
[TBL] [Abstract][Full Text] [Related]
25. Liquid chromatographic determination of sodium mercaptoundecahydrododecaborate in rat urine and plasma after precolumn derivatization.
Abu-Izza K; Lu DR
J Chromatogr B Biomed Appl; 1994 Oct; 660(2):347-52. PubMed ID: 7866525
[TBL] [Abstract][Full Text] [Related]
26. A high-performance liquid chromatographic assay for CI-973, a new anticancer platinum diamine complex, in human plasma and urine ultrafiltrates.
Bullen WW; Andress LD; Chang T; Whitfield LR; Welch ML; Newman RA
Cancer Chemother Pharmacol; 1992; 30(3):193-8. PubMed ID: 1628368
[TBL] [Abstract][Full Text] [Related]
27. Determination of 3'-C-ethynylcytidine in human plasma and urine by liquid chromatographic-electrospray ionization tandem mass spectrometry.
Matsuoka K; Kitamura R; Matsushima E; Kawaguchi Y
J Pharm Biomed Anal; 2003 Feb; 31(1):47-55. PubMed ID: 12560048
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous determination of a new anticancer agent (NB-506) and its active metabolite in human plasma and urine by high-performance liquid chromatography with ultraviolet detection.
Takenaga N; Ishii Y; Monden S; Sasaki Y; Hata S
J Chromatogr B Biomed Appl; 1995 Dec; 674(1):111-7. PubMed ID: 8749258
[TBL] [Abstract][Full Text] [Related]
29. Optimisation of a reversed-phase high-performance liquid chromatographic method for the determination of flavone acetic acid and its major human metabolites in plasma and urine.
Cummings J; Kerr DJ; Kaye SB; Smyth JF
J Chromatogr; 1988 Sep; 431(1):77-85. PubMed ID: 3235538
[TBL] [Abstract][Full Text] [Related]
30. Liquid chromatographic analysis in mouse, dog and human plasma; stability, absorption, metabolism and pharmacokinetics of the anti-HIV agent 2-chloro-5-(2-methyl-5,6-dihydro-1,4-oxathiin-3-yl carboxamido) isopropylbenzoate (NSC 615985, UC84).
Nomeir AA; McComish MF; Ferrala NF; Silveira D; Covey JM; Chadwick M
J Pharm Biomed Anal; 1998 May; 17(1):27-38. PubMed ID: 9608423
[TBL] [Abstract][Full Text] [Related]
31. Plasma disposition, metabolism and excretion of the experimental antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the mouse, rat and rabbit.
Kestell P; Paxton JW; Rewcastle GW; Dunlop I; Baguley BC
Cancer Chemother Pharmacol; 1999; 43(4):323-30. PubMed ID: 10071984
[TBL] [Abstract][Full Text] [Related]
32. High-performance liquid chromatographic assay for the experimental anticancer agent oxantrazole.
Frank SK; Mathiesen DA; Whitfield LR; Ames MM
J Chromatogr; 1987 Aug; 419():225-32. PubMed ID: 3667780
[TBL] [Abstract][Full Text] [Related]
33. Development of a sensitive bioanalytical method for the quantification of lacosamide in rat plasma. Application to preclinical pharmacokinetics studies in rats.
Shah S; Vasantharaju SG; Arumugam K; Muddukrishna BS; Desai N
Arzneimittelforschung; 2012 May; 62(5):243-6. PubMed ID: 22382788
[TBL] [Abstract][Full Text] [Related]
34. Determination of LY295501 in human plasma by reverse phase HPLC with UV detection.
Berna M; Wood P
J Pharm Biomed Anal; 1999 Sep; 20(5):799-805. PubMed ID: 10701988
[TBL] [Abstract][Full Text] [Related]
35. High-performance liquid chromatographic assay and preclinical pharmacological studies of pibenzimol (bisbenzimidazole).
Ames MM; Miller KJ; Moertel DM
J Chromatogr; 1985 May; 341(1):89-96. PubMed ID: 2410440
[TBL] [Abstract][Full Text] [Related]
36. The impact of column temperature in the high performance liquid chromatographic analysis of topotecan in rat and dog plasma.
Rosing H; Doyle E; Beijnen JH
J Pharm Biomed Anal; 1996 Nov; 15(2):279-86. PubMed ID: 8933430
[TBL] [Abstract][Full Text] [Related]
37. Reversed-phase high-performance liquid chromatographic determination of tricyclic nucleoside and tricyclic nucleoside 5'-phosphate in biological specimens.
Schilcher RB; Young JD; Baker LH
J Chromatogr; 1985 Jan; 337(1):55-62. PubMed ID: 3980657
[TBL] [Abstract][Full Text] [Related]
38. Preclinical pharmacokinetics and stability of isophosphoramide mustard.
Zheng JJ; Chan KK; Muggia F
Cancer Chemother Pharmacol; 1994; 33(5):391-8. PubMed ID: 8306413
[TBL] [Abstract][Full Text] [Related]
39. Determination of the oral platelet aggregation inhibitor Sibrafiban in rat, dog, and human plasma utilising HPLC-column switching combined with turbo ion spray single quadrupole mass spectrometry.
Timm U; Birnböck H; Erdin R; Hopfgartner G; Zumbrunnen R
J Pharm Biomed Anal; 1999 Oct; 21(1):151-63. PubMed ID: 10701922
[TBL] [Abstract][Full Text] [Related]
40. Optimization and validation of RP-HPLC-UV method with solid-phase extraction for determination of buparvaquone in human and rabbit plasma: application to pharmacokinetic study.
Venkatesh G; Majid MI; Ramanathan S; Mansor SM; Nair NK; Croft SL; Navaratnam V
Biomed Chromatogr; 2008 May; 22(5):535-41. PubMed ID: 18205140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
